Towards Healthcare
Newborn Screening Market Grows at 6.5% CAGR by 2034

Newborn Screening Market Size, Regional Insights and Strategic Forecasts

According to market projections, the newborn screening sector is expected to grow from USD 3.44 billion in 2024 to USD 6.46 billion by 2034, reflecting a CAGR of 6.5%. The market is growing due to rising demand for preventive care, advanced diagnostic technologies, and increased awareness of testing. Recent highlights include the GUARDIAN study using genome sequencing and a $2M grant to Emory University to enhance screening programs in the U.S. Southeast.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Newborn Screening Market Assessment

  • Overview
  • Global Newborn Screening Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments
    • Reagents
    • Software and Data Management Systems
  • Global Newborn Screening Market Size Value (US$) and Volume (Billion Tons), by Test Type (2021 – 2033)
    • Blood Tests
    • Heart Screening
    • Hearing Screening
    • Other Tests
  • Global Newborn Screening Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Tandem Mass Spectrometry
    • Pulse Oximetry
    • Enzyme Based Assay
    • DNA Assay
    • Electrophoresis
    • Others
  • Global Newborn Screening Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Newborn Screening Market Assessment

  • Overview
  • North America Newborn Screening Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments
    • Reagents
    • Software and Data Management Systems
  • North America Newborn Screening Market Size Value (US$) and Volume (Billion Tons), by Test Type (2021 – 2033)
    • Blood Tests
    • Heart Screening
    • Hearing Screening
    • Other Tests
  • North America Newborn Screening Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Tandem Mass Spectrometry
    • Pulse Oximetry
    • Enzyme Based Assay
    • DNA Assay
    • Electrophoresis
    • Others

Europe Newborn Screening Market Assessment

  • Overview
  • Europe Newborn Screening Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments
    • Reagents
    • Software and Data Management Systems
  • Europe Newborn Screening Market Size Value (US$) and Volume (Billion Tons), by Test Type (2021 – 2033)
    • Blood Tests
    • Heart Screening
    • Hearing Screening
    • Other Tests
  • Europe Newborn Screening Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Tandem Mass Spectrometry
    • Pulse Oximetry
    • Enzyme Based Assay
    • DNA Assay
    • Electrophoresis
    • Others

Asia Pacific Newborn Screening Market Assessment

  • Overview
  • Asia Pacific Newborn Screening Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments
    • Reagents
    • Software and Data Management Systems
  • Asia Pacific Newborn Screening Market Size Value (US$) and Volume (Billion Tons), by Test Type (2021 – 2033)
    • Blood Tests
    • Heart Screening
    • Hearing Screening
    • Other Tests
  • Asia Pacific Newborn Screening Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Tandem Mass Spectrometry
    • Pulse Oximetry
    • Enzyme Based Assay
    • DNA Assay
    • Electrophoresis
    • Others

Middle East and Africa Newborn Screening Market Assessment

  • Overview
  • Middle East and Africa Newborn Screening Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments
    • Reagents
    • Software and Data Management Systems
  • Middle East and Africa Newborn Screening Market Size Value (US$) and Volume (Billion Tons), by Test Type (2021 – 2033)
    • Blood Tests
    • Heart Screening
    • Hearing Screening
    • Other Tests
  • Middle East and Africa Newborn Screening Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Tandem Mass Spectrometry
    • Pulse Oximetry
    • Enzyme Based Assay
    • DNA Assay
    • Electrophoresis
    • Others

South America Newborn Screening Market Assessment

  • Overview
  • South America Newborn Screening Market Size Value (US$) and Volume (Billion Tons), by Product Type (2021 – 2033)
    • Instruments
    • Reagents
    • Software and Data Management Systems
  • South America Newborn Screening Market Size Value (US$) and Volume (Billion Tons), by Test Type (2021 – 2033)
    • Blood Tests
    • Heart Screening
    • Hearing Screening
    • Other Tests
  • South America Newborn Screening Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Tandem Mass Spectrometry
    • Pulse Oximetry
    • Enzyme Based Assay
    • DNA Assay
    • Electrophoresis
    • Others

Company Profiles

  • Bio-Rad Laboratories Inc.
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Agilent Technologies Inc.
  • Natus Medical Inc.
  • Waters
  • Siemens Healthineers AG
  • Bruker
  • GE HealthCare
  • Medtronic
  • Trivitron Healthcare
  • Masimo Corporation

Conclusion & Recommendations

  • Insight Code: 5128
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: May 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

Newborn screening is a simple test done shortly after birth to check for serious but treatable health conditions in newborn babies, usually by pricking the babys heel to collect a small blood sample.

Newborn screening helps detect potential health issues early, allowing for timely intervention and treatment. This can prevent serious health problems and improve newborn outcomes.

North America leads the market for newborn screening.

National Institute of Health, Centers for Disease Control and Prevention, World Health Organization, ScienceDirect, HealthData.gov.